Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Korean Journal of Internal Medicine|April 7, 2016
Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer CommitteeMoon Jin Kim, Young Sam Kim, Sung Yong Oh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2015
Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effectsIn Gyu Hwang, Jung Hun Kang, Sung Yong Oh, et al.
Leukemia & Lymphoma|September 29, 2015
A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trialSung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Cancer Research and Treatment|August 5, 2016
Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study ResultsYeon Hee Park, Tae Yong Kim, Young-Hyuck Im, et al.
Cytokine|March 26, 2021
Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13)Ju Won Kim, Soohyeon Lee, Hye Sook Kim, et al.
Cancer Communications (London, England)|October 18, 2019
Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
International Journal of Hematology|October 16, 2012
Waldeyer's ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL)Sung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Cancer Science|September 14, 2010
Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Cancer Research and Treatment|July 20, 2019
Clinical Characteristics of Clear Cell Ovarian Cancer: A Retrospective Multicenter Experience of 308 Patients in South KoreaHee Yeon Lee, Ji Hyung Hong, Jae Ho Byun, et al.
The Oncologist|September 8, 2019
A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin ToxicitiesYoung Saing Kim, Jun Ho Ji, Sung Yong Oh, et al.
Pageof 9